Physician profile
Jana Keating
NPI 1356683619
$3,383.04
in general payments reported to CMS, 2019-2025
12 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $16.96 · 2021: $61.53 · 2022: $108 · 2023: $71.26 · 2024: $1,517 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $88.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $88.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,016.99 | 2024-2025 | |
| Abbvie INC. | $119.72 | 2019-2022 | |
| Astellas Pharma US INC | $45.64 | 2019-2023 | Veozah, Myrbetriq |
| Roche Diagnostics Corporation | $36.95 | 2019 | |
| Hologic Sales and Service, LLC | $29.27 | 2019-2022 | |
| Daiichi Sankyo INC. | $29.26 | 2019-2020 | |
| Avion Pharmaceuticals | $25.87 | 2021 | |
| Mayne Pharma Commercial LLC | $24.73 | 2023 | |
| Therapeuticsmd, INC. | $16.86 | 2022 | |
| Shield Therapeutics INC | $13.79 | 2023 | Accrufer |
| Smith+Nephew, INC. | $12.02 | 2022 | |
| Pfizer INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.